Overcoming the UCB HSCs –Derived NK cells Dysfunction through Harnessing RAS/MAPK, IGF-1R and TGF-β Signaling Pathways
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overcoming the UCB HSCs –Derived NK cells Dysfunction through Harnessing RAS/MAPK, IGF-1R and TGF-β Signaling Pathways
Authors
Keywords
-
Journal
Cancer Cell International
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-07
DOI
10.1186/s12935-021-01983-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence
- (2020) Sean J. Judge et al. Frontiers in Cellular and Infection Microbiology
- HSP70/IL-2 Treated NK Cells Effectively Cross the Blood Brain Barrier and Target Tumor Cells in a Rat Model of Induced Glioblastoma Multiforme (GBM)
- (2020) Farzaneh Sharifzad et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy
- (2019) Fernando Souza-Fonseca-Guimaraes et al. TRENDS IN IMMUNOLOGY
- NK cell metabolism
- (2019) Clair M. Gardiner JOURNAL OF LEUKOCYTE BIOLOGY
- NKG2A is a NK cell exhaustion checkpoint for HCV persistence
- (2019) Chao Zhang et al. Nature Communications
- Safety and efficacy of ex vivo expanded CD34+ stem cells in murine and primate models
- (2019) Yu Zhang et al. Stem Cell Research & Therapy
- A simple method for in vitro preparation of natural killer cells from cord blood
- (2019) Yong Xu Mu et al. BMC BIOTECHNOLOGY
- Enhanced cancer immunotherapy with Smad3-slilencing NK-92 cells
- (2018) Qing Ming Wang et al. Cancer Immunology Research
- Ex vivo expansion of CD3 depleted cord blood-MNCs in the presence of bone marrow stromal cells; an appropriate strategy to provide functional NK cells applicable for cellular therapy
- (2017) Ehteramolsadat Hosseini et al. Stem Cell Research
- IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours
- (2017) Hyungseok Seo et al. Nature Communications
- Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development
- (2017) Patrick Ming-Kuen Tang et al. Nature Communications
- Developmental and Functional Control of Natural Killer Cells by Cytokines
- (2017) Yang Wu et al. Frontiers in Immunology
- NK Cell Exhaustion
- (2017) Jiacheng Bi et al. Frontiers in Immunology
- Challenges of cancer therapy with natural killer cells
- (2015) Hans Klingemann CYTOTHERAPY
- Present and Future of Allogeneic Natural Killer Cell Therapy
- (2015) Okjae Lim et al. Frontiers in Immunology
- Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy
- (2015) Cariad Chester et al. Frontiers in Immunology
- Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) – From Preclinical Studies to a Clinical Phase II Trial
- (2015) Hanno M. Specht et al. Frontiers in Immunology
- Molecular mechanisms of natural killer cell activation in response to cellular stress
- (2013) C J Chan et al. CELL DEATH AND DIFFERENTIATION
- IL-2–dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells
- (2013) Georg Gasteiger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IGF-1 promotes the development and cytotoxic activity of human NK cells
- (2013) Fang Ni et al. Nature Communications
- Wnt1 Accelerates anEx VivoExpansion of Human Cord Blood CD34+CD38−Cells
- (2013) Kamonnaree Chotinantakul et al. Stem Cells International
- Natural Killer Cell Differentiation from Hematopoietic Stem Cells: A Comparative Analysis of Heparin- and Stromal Cell–Supported Methods
- (2011) Steven A. Dezell et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Ex vivo differentiation of natural killer cells from human umbilical cord blood CD34+progenitor cells
- (2011) Maria João Pinho et al. CELL COMMUNICATION AND ADHESION
- Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
- (2011) Jan Spanholtz et al. PLoS One
- Inducible Hsp70 in the Regulation of Cancer Cell Survival: Analysis of Chaperone Induction, Expression and Activity
- (2011) Elisa Zorzi et al. Cancers
- IL-7 Enhances Survival of Human CD56bright NK Cells
- (2010) Annie Michaud et al. JOURNAL OF IMMUNOTHERAPY
- IL-2−driven Regulation of NK Cell Receptors With Regard to the Distribution of CD16+ and CD16− Subpopulations and In Vivo Influence After Haploidentical NK Cell Infusion
- (2010) Sabine Huenecke et al. JOURNAL OF IMMUNOTHERAPY
- High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy
- (2010) Jan Spanholtz et al. PLoS One
- Activation of natural killer cells by heat shock protein 70
- (2009) Gabriele Multhoff INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Interleukin-21 activates human natural killer cells and modulates their surface receptor expression
- (2007) Kresten Skak et al. IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now